XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED BALANCE SHEET - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash & Investments $ 93,808 $ 92,868
Accounts & other receivables, net 3,591 3,391
Inventories 9,240 9,582
Other current assets 510 428
Total current assets 107,149 106,269
Property and equipment, net 10,266 10,551
Goodwill 13,638 13,692
Other intangible assets 54,029 54,296
Other intangible assets - accumulated amortization (49,641) (49,350)
Other intangible assets, net 4,388 4,946
Total assets 135,441 135,458
Current liabilities    
Accounts payable 998 769
Accrued expenses 4,476 3,941
Total current liabilities 5,474 4,710
Deferred tax liability - Femcare IIA 986 1,120
Other long term liabilities 698 698
Long-term lease liability 285 295
Deferred income taxes 256 322
Total liabilities 7,699 7,145
Stockholders' equity    
Common stock - $.01 par value; authorized - 50,000 shares; issued and outstanding - March 31, 2024, 3,588 shares and December 31, 2023, 3,628 shares 36 36
Accumulated other comprehensive loss (11,289) (10,658)
Additional paid-in capital 0 594
Retained earnings 138,995 138,341
Total stockholders' equity 127,742 128,313
Total liabilities and stockholders' equity $ 135,441 $ 135,458